Study: Experimental Drug Reverses Obesity-Related Liver Disease

Researchers at the University of Rochester Medical Centre (URMC) in the US have developed a drug called URMC-099 that protects mice from non-alcoholic fatty liver disease, which is caused by a high-fat diet. Obesity often leads to non-alcoholic fatty liver disease. Individuals with the most severe form of the disease,…
subscribe here